Furthermore, as highlighted within this review, the nuclear envelope proteins are extensively involved in the hallmarks of cancer, suggesting a nuclear envelope targeting cancer drug has the potential to have a potent, multifaceted mechanism of inducing cell death in tumour cells. This evidence concerns the gene SUN2 and cancer.